METASTATIC COLORECTAL CANCER MCRC WITH WILD-TYPE RAS: THE CONTINUATION OF ANTI-EGFR THERAPY WITH A CHANGE OF CHEMOTHERAPY AFTER DISEASE PROGRESSION. (2017). Voprosy Onkologii, 63(3), 456-460. https://doi.org/10.37469/0507-3758-2017-63-3-456-460